First-Line Pembrolizumab Mono- or Combination Therapy of Non-Small Cell Lung Cancer: Baseline Metabolic Biomarkers Predict Outcomes

SIMPLE SUMMARY: Positron-emission tomography/computed tomography (PET/CT) is used for staging of non-small cell lung cancer (NSCLC) and can help to estimate prognosis in patients treated with immune checkpoint inhibitor (ICI) therapy. Most available data in that field were derived from cohorts treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, David, Ritzberger, Linda, Rambousek, Vanessa, Horner, Andreas, Wass, Romana, Akbari, Kaveh, Kaiser, Bernhard, Kronbichler, Jürgen, Lamprecht, Bernd, Gabriel, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656760/
https://www.ncbi.nlm.nih.gov/pubmed/34885206
http://dx.doi.org/10.3390/cancers13236096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656760/
https://www.ncbi.nlm.nih.gov/pubmed/34885206
http://dx.doi.org/10.3390/cancers13236096

Ejemplares similares